November 2020
Pharmacist Contributions to Patient Care in Cervical and Endometrial Cancers: From Prevention to Metastatic Disease
December 23, 2020
Article
Directions in Pharmacy
In a live 2020 Directions in Oncology Pharmacy® conference session, the presenter provided an update on the management of cervical and endometrial cancers.
Essential Updates in Acute Graft-Versus-Host Disease
December 22, 2020
Article
Directions in Pharmacy
In a live 2020 Directions in Oncology Pharmacy® conference session, an update on research in the past decade that has led to improvements in the diagnosis, risk stratification, prevention, and treatment of acute graft-versus-host disease was provided.
Practice-Changing Clinical Pearls in Relapsed or Refractory Multiple Myeloma
December 21, 2020
Article
Directions in Pharmacy
Three monoclonal antibodies, 1 antibody-drug conjugate, and 1 nuclear export inhibitor have been approved by the FDA for relapsed/refractory (R/R) multiple myeloma in the past 4 years.
Cancer Care During the COVID-19 Pandemic
December 18, 2020
Article
Directions in Pharmacy
The COVID-19 pandemic has accelerated both acceptance and payment of novel care delivery models including telehealth.
Spotlight on BTK Inhibitors in the Management of B-Cell Malignancies
December 17, 2020
Article
Directions in Pharmacy
A live 2020 Directions in Oncology Pharmacy® conference session emphasized pharmacist involvement in optimizing therapy with BTK inhibitors.
Bispecific Antibodies: The Next Generation of Immunotherapy
December 16, 2020
Article
Directions in Pharmacy
Advances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.
Brown Bag Consult: Offering Preventative Cancer Care in the Community Pharmacy
December 16, 2020
Article
Directions in Pharmacy
Counseling patients on possible adverse effects that impact skin health can help patients prepare for serious or cosmetic impacts.
Oncology Drug Pipeline Is Poised to Offer Potential New Therapies in the Next Year
December 15, 2020
Article
Directions in Pharmacy
The specialty drug pipeline is coming off a strong year, and the oncology pipeline has a wealth of potential oncolytics.
Recent Developments in Therapeutics for GIST, Non–Small Cell Lung Cancer
December 04, 2020
Article
Directions in Pharmacy
Targeted therapies often have better toxicity profiles, allowing patients to remain adherent and stay on medications longer.
CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory Lymphomas
December 03, 2020
Article
Directions in Pharmacy
Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.
The New Norm in Oncology Pharmacy
November 30, 2020
Article
Directions in Pharmacy
How has COVID-19 impacted our professional lives in providing care to patients with cancer, who are at even greater risk of contracting the virus and more likely to have higher morbidity and mortality should they be infected?
Breast Cancer Testing, Counseling, and Toxicity Management Are Essential for Optimal Oncology Care
November 25, 2020
Article
Directions in Pharmacy
Pharmacists can play an integral role in educating patients with breast cancer to improve health outcomes.
Pharmacy-Integrated Telehealth Solutions Support Patients with Orphan and Ultraorphan Disorders During and After COVID-19 Pandemic
November 24, 2020
Article
Directions in Pharmacy
A recent poll showed that more than 1 in 8 Americans engaged in a video consult with a health care professional in recent months.
Managing Toxicities Associated With Immune Checkpoint Inhibitors
November 24, 2020
Article
Directions in Pharmacy
Although ICIs have demonstrated excellent efficacy, they also have been associated with unique irAEs.
CE: Managing Chronic Immune Thrombocytopenia: Opportunities for Oncology Pharmacists to Optimize Patient Care
November 22, 2020
Article
Directions in Pharmacy
This activity is supported by educational grants from Dova Pharmaceuticals, INC. and Cure Media Group.
Rising to Meet the Challenges of COVID-19 in Cancer Care
November 20, 2020
Article
Directions in Pharmacy
This month, Directions in Oncology Pharmacy® highlights a variety of ways that cancer care treatments are evolving, along with how practices are evolving, including best practices for the safety of health care workers such as oncology pharmacists.
Best Practices for Safety, Workflow When Using Hazardous Agents
November 19, 2020
Article
By supplying proper PPE and infrastructure, health systems can keep workers safe and provide excellent patient care.
Rare Pharmacy Emerges From Specialty, Part 3
November 18, 2020
Article
Directions in Pharmacy
The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.
Program Offering Enhanced Reimbursement for High-Quality Drugs Impacts Prescribing Patterns
November 16, 2020
Article
Directions in Pharmacy
Prescriptions for evidence-based cancer drugs increased under a pay-for-performance program without significantly impacting cost of care.